Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | CUPR | PPCB | ||
| Company | Phasebio Pharmaceuticals Inc | Cuprina Holdings [Cayman] Limited | Propanc Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0800 | 5.45 | 1.4200 | ||
| High | 0.0920 | 7.35 | 1.4650 | ||
| Low | 0.0665 | 5.13 | 1.4011 | ||
| Latest | 0.0701 | 5.68 | 1.4500 | ||
| Change | -0.0249 | +1.74 | -0.0200 | ||
| % Change | -26.21% | +44.16% | -1.36% | ||
| Volume | 9,647,400 | 24,034,595 | 39,186 | ||
| 20-Day Average Volume | 3,930,150 | 8,183,463 | 8,954,822 | ||
| Previous Close | 0.0950 | 3.94 | 1.4700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 3.58 | 1.6946 | ||
| 20-Day Raw Stochastic | 2.27% | 29.60% | 2.14% | ||
| 20-Day Relative Strength | 20.88 | 60.12 | 39.47 | ||
| Weighted Alpha | -91.26 | -59.67 | -97.67 | ||
| Today's Opinion | 100% Sell | 24% Buy | 100% Sell | ||
| Previous Opinion | 100% Sell | 8% Buy | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | +7.97% since 06/16/26 | -26.56% since 06/16/26 | ||
| Low | 0.0665 on 11/02/22 | 3.70 on 06/18/26 | 1.3515 on 06/23/26 | ||
| High | 0.1440 on 10/27/22 | 7.27 on 06/24/26 | 1.8800 on 06/17/26 | ||
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | +163.52% since 05/22/26 | -19.47% since 05/22/26 | ||
| Low | 0.0665 on 11/02/22 | 1.86 on 05/27/26 | 1.3000 on 06/10/26 | ||
| High | 0.2250 on 10/14/22 | 14.80 on 06/15/26 | 6.7900 on 06/11/26 | ||
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | +116.71% since 03/24/26 | -48.83% since 03/24/26 | ||
| Low | 0.0665 on 11/02/22 | 1.76 on 05/13/26 | 1.3000 on 06/10/26 | ||
| High | 1.3800 on 08/09/22 | 14.80 on 06/15/26 | 6.7900 on 06/11/26 | ||
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | +48.61% since 12/24/25 | -91.41% since 12/24/25 | ||
| Low | 0.0665 on 11/02/22 | 1.76 on 05/13/26 | 1.3000 on 06/10/26 | ||
| High | 1.3800 on 08/09/22 | 14.80 on 06/15/26 | 16.1250 on 12/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 3,627 | 3,349 | ||
| Shares Outstanding, K | 49,858 | 921 | 2,278 | ||
| Annual Sales | 10,830,000 | 40,000 | 0 | ||
| Annual Net Income | -131,070,000 | -3,630,000 | -58,920,000 | ||
| Last Quarter Sales | 210,000 | N/A | 0 | ||
| Last Quarter Net Income | -16,670,000 | N/A | -6,360,000 | ||
| 60-Month Beta | 2.57 | 2.31 | 3.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | N/A | -7.00 on 05/14/26 | ||
| Earnings Date | 11/09/22 | 07/27/26 | 10/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||